Takeda Expects Stronger Net Profit On Lower Tax

Entyvio Again Drives Growth In Q3

Entyvio strong again for Japanese firm as it raises net profit forecast on lower tax costs. Meanwhile, 'Wave 1' pipeline projects are progressing, with simultaneous development in major markets a key goal. 

inflammatory bowel disease
Entyvio Again The Main Growth Driver For Takeda • Source: Shutterstock

More from Business

More from Scrip